Plain-English translation of NCT07584577 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether malnourished patients with esophageal or stomach cancer benefit from nutritional support given through a feeding tube (called a jejunostomy) during their chemotherapy and radiation treatment before surgery. Many patients with these cancers lose weight and become malnourished, which can make surgery recovery harder and treatment side effects worse. The study wants to see if providing extra nutrition during treatment helps reduce complications after surgery.
Many patients with esophageal and stomach cancer are malnourished when diagnosed, and this makes them weaker before surgery and more likely to have serious complications during recovery. While doctors believe that better nutrition before surgery helps, there is no clear guidance on the best way to provide that nutrition or how long to do it. This trial aims to find out if feeding tube nutrition during cancer treatment truly improves surgical outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will either receive nutritional support through a feeding tube during your cancer treatment (the treatment group) or continue with standard care without the feeding tube (the control group). You will be followed throughout your cancer treatment and then monitored after your surgery to see how well you recover and whether you develop any complications. The study involves visits to track your nutrition, weight, and overall health before, during, and after your treatment and surgery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France
Sponsor
University Hospital, Bordeaux
Collaborators
French Eso-Gastric Tumors Working Group
Enrollment target
~670 participants
Started
November 2026
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Caroline GRONNIER, PhD, MD
University Hospital, Bordeaux
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.